Open report — full analysis, no account required.
Sign up to generate reports and read filings that aren't on the open list.
Get notified when PIII files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsP3 Health Partners shareholders approve warrant exercise for 3.3M shares
Filed June 10, 2026 · Period ending June 9, 2026 · ~1 min read
Key Changes
-
medium
Shareholders authorized issuance of up to 3,341,130 Class A shares upon exercise of warrants held by VBC Growth SPV 5, LLC, representing potential dilution to existing holders.
Item 5.07: Warrant Authorization verify on EDGAR → -
low
Three Class II directors elected to serve until 2029 annual meeting: Dr. Amir Bacchus, Mark Thierer, and Lawrence B. Leisure.
Item 5.07: Director Elections verify on EDGAR → -
low
BDO USA, P.C. ratified as independent auditor for fiscal year 2026 with over 99% approval.
Item 5.07: Auditor Ratification verify on EDGAR →
Summary
P3 Health Partners held its 2026 Annual Meeting on June 9, where shareholders voted on routine governance matters and one potentially dilutive proposal. The most significant item was approval to issue up to 3.3 million Class A shares upon exercise of warrants held by VBC Growth SPV 5, LLC. This represents meaningful potential dilution for current shareholders if the warrants are exercised.
The meeting also included standard annual business: electing three directors to three-year terms and ratifying the company's auditor. All proposals passed with strong support. For warrant holders (PIIIW), watch for any announcements regarding warrant exercise by VBC Growth SPV 5, as this could trigger the authorized share issuance and impact the common stock's trading dynamics.
Section-by-Section Diff
Event · Item 5.07 — Submission of Matters to a Vote of Security Holders
P3 Health Partners held its 2026 Annual Meeting on June 9, 2026, electing three Class II directors and approving auditor ratification, executive compensation, and warrant exercise authorization.
Show 2 minor / wording changes
Added in current filing · verify on EDGAR →
Proposal 1 — Election of three Class II directors for a term of office expiring on the date of the annual meeting of stockholders to be held in 2029, and until their respective successors have been duly elected and qualified.
Three Class II directors were elected at the Annual Meeting: Amir Bacchus, M.D. (4,067,100 votes for), Mark Thierer (4,081,573 votes for), and Lawrence B. Leisure (3,980,136 votes for). All three nominees were elected to serve until the 2029 annual meeting.
Added in current filing · verify on EDGAR →
Proposal 2 — Ratification of the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
Shareholders ratified the appointment of BDO USA, P.C. as the Company's independent auditor for fiscal year 2026, with 4,484,963 votes for, 39,585 against, and 224 abstentions. This is a routine annual approval.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Jun 10, 2026 · How we verify